Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple step test replace the 6-Minute walk for heart rehab?

NCT ID NCT04699136

Knowledge-focused Sponsor: Lille Catholic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a 6-minute stepper test (ST6) can accurately measure exercise tolerance in people with heart conditions undergoing rehabilitation. Researchers compared the stepper test results with the standard 6-minute walk test and a cardiac stress test in 60 patients. The goal was to see if the stepper test is a valid, practical alternative for assessing heart patients' fitness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a simpler, space-saving way to assess exercise capacity in heart patients during rehabilitation.
What could go wrong
This is a small, completed validation study, not a treatment trial. The stepper test may not prove as reliable as existing methods for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2021

Finished

Apr 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years old, * Patient with a cardiac pathology (coronary bypass, valve replacement, heart transplant, coronary angioplasty), * Registered in Cardiovascular Rehabilitation at the Mitterie Clinic, * Number of rehabilitation sessions at least equal to 30, * Ejection fraction ≥ 45%, * Signed written consent of the patient, * Affiliation to a social security scheme. Exclusion Criteria: * Cardiac decompensation, * Severe functional limitation, * Unstable acute coronary syndrome, * Decompensated heart failure, * Severe ventricular rhythm disorders, * Presence of an intracardiac thrombus with high embolic risk, * Presence of a medium to large pericardial effusion (effusion of more than 10mm circumferential or 14mm localized on ultrasound), * Recent history (months prior to inclusion) of thrombophlebitis with or without pulmonary embolism, * Severe and/or symptomatic left ventricular ejection obstruction, * Any progressive inflammatory and/or infectious disease, * Severe pulmonary arterial hypertension, * Oxygen therapy, * Musculoskeletal or balance problems that would limit the ability to do any of the following the fiscal year. * Pregnant or breastfeeding women, * Incapacity to consent (including persons under guardianship or curatorship)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac disease

Contacts and locations

Locations

  • Clinique de la Mitterie

    Lille, 59160, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.